Aehr Test Systems Stock Soars After Q4 Results — Here's Why

Benzinga Earnings
Jul 15

Aehr Test Sytems (NASDAQ:AEHR) stock soared after the company posted fourth-quarter results after Tuesday’s closing bell, beating estimates on the top and bottom lines.  

Here’s a look at the details inside the report. 

  • AEHR stock is moving. Watch the price action here.

Aehr Test Systems Q4 Details       

Aehr Test Systems reported quarterly earnings of 11 cents per share, which beat the analyst consensus estimate for a loss of one cent, according to Benzinga Pro data.

Quarterly revenue clocked in at $18.84 million, which beat the Street estimate of $18.69 million and was up from $14.09 million in the same period last year.

Aehr reported the following quarterly highlights:

  • Net revenue was $18.8 million, compared to $14.1 million in the fourth quarter of fiscal 2025.
  • Bookings were a record $60.7 million for the quarter.
  • Backlog as of May 29, 2026, was $80.6 million. Effective backlog, including bookings since May 29, 2026, is $100.6 million.

“We are very pleased with our fiscal fourth quarter performance, which exceeded expectations and capped a year of significant bookings and revenue diversification for Aehr,” CEO Gayn Erickson said.

“Record quarterly bookings, a very strong backlog, and growing demand across AI processors, silicon photonics and power semiconductors for our wafer-level and package-level burn-in solutions position us well for significant growth moving forward,” Erickson added.

Read Also: IBM Heads for Worst Day Ever, But Why Are Cybersecurity Stocks Up?

Looking Ahead

Aehr expects fiscal 2027 revenue in a range of $130 million to $150 million, versus the $85.13 million analyst estimate.

AEHR Stock Price Activity: According to data from Benzinga Pro, Aehr Test Systems stock was up 23.29% to $88.78 in Tuesday’s extended trading.  

Photo: Shutterstock

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10